Atlas Trials

Patient-derived Organoid Drug Sensitivity Guided Treatment for Recurrent Small Cell Lung Cancer

Clinical trial NCT06406660 · UNKNOWN

Trial details

NCT number
NCT06406660
Sponsor
Henan Cancer Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Small Cell Lung Cancer
Start date
2024-04-16
Primary completion
2025-12-16
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.